Although β-actin loading was not very even in Figure 5B, as we were not quantitatively comparing the expression of RUNX2/3 between the samples, the β-actin blot was adequate to serve as a loading control to indicate that RUNX2, but not RUNX3, was detected in these human GCT tissues. The gene discussed is RUNX2; the disease is granular cell tumor.